semaglutide centennial – julymd Semaglutide Injection for Seniors With

Responsive support and clear navigation improve both safety and convenience when managing semaglutide therapy

One of the standout advantages of GLP-1 agonists is their cardiovascular benefit

The differences in ADP scores compared with placebo were 1.17 (95% confidence interval [CI], 1.84 to 0.50) for 60 mg/day and 1.45 (95% CI, 2.13 to 0.78) for 120 mg/day [46]

Many of our patients pair peptide therapy with our IV drip treatments for even greater results

The benefits build gradually as your body restores healthy B12 levels

Use of GLP-1 (drugs) is rapidly expanding in this population, highlighting an important area for future research.More informationThe Mayo Clinic has more on GERD.SOURCES: Annals of Internal Medicine, July 14, 2025